IBD Essentials

Taku Kobayashi from Tokyo talks about special aspects of IBD management in Japan, monitoring strategies and medical treatment in Japanese IBD patients including apheresis, tacrolimus, differences in the diseae course of...

Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD, intestinal fibrosis expert and principal investigator of the new treatment option with the oral GI-restricted small molecule inhibitor...

Paulo Kotze, Curtiba, Brazil, talks about special aspects of IBD management in South America, Early Surgery in Crohn's disease, appendectomy as a new treatment option in ulcerative colitis and the emerging role of...

Dr. Sara El Ouali, UAE, talks about the rise of IBD in the mid-east, special aspects of IBD management in the Middle-East and career pathways of women in GI and IBD, including gender disparities, difficult career paths...

Jean-Fred Colombel, Mount Sinai Hospital New York City, USA, talks about his biography and personal pathway in IBD and options of very early diagnosis of IBD and strategies to prevent the onset of IBD (interception) and...

<p>Bruce Sands, Mount Sinai Hospital New York City, USA, talks about his biography and personal pathway in IBD and options of breaking the therapeutic ceiling in IBD including combination therapy, treat to target and...

<p>Matthieu Allez, Montreal, talks about the management of postoperative Crohn's disease, prediction of relapse rates, monitoring strategies in the postoperative setting, risk factors for postoperative recurrence and...

<p>Pradeep Bhandari from Portsmouth (UK) on recent BSGE guidelines of chromoendoscopy, co-hosted by Raf Bisschops.</p>

<p>Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD</p>

<p>Matthieu Allez, Montreal talks about cell-based therapeutic approaches in refractory or complicated IBD covering hematopoetic stem cell transplantation and CAR T cell therapies, indication for this treatment options...

<p>Dr. Saurabh Mehandru, Mount Sinai Hospital in New York, internationally recognized physician scientist in IBD and global leader in B cell biology in intestinal health and inflammation discussed the role of B cells in...

<p>Ailsa Hart, St. Marks Hospital, London, UK, internationally renowned IBD expert talks about strategies to optimize the management of perianal fistulising Crohn's disease, relevance of MDT approaches, building...

<p>Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD and intestinal fibrosis expert talks about his fundamental work and participation in intestinal fibrosis, spanning from basic...

<p>Andreas Sturm, gastroenterologist and IBDand medical guideline expert from Berlin, discusses about the development of evidence based guidelines and the relevance to improve the management of patients with IBD and the...

<p>Paulo Sousa from Porto, current chair of the young talent group of UEG, reflects why she decided to become a gastroenterologist and to pursue a career in IBD. She describes how UEG may help tom foster a career in...